LGALS3BP and metabolic dysfunction-associated steatohepatitis: WFA+ -M2BP level was found to be significantly increased in the fibrotic NASH and NASH cirrhosis groups compared to healthy controls and those with NAFL or early NASH after adjusting for age, gender and BMI (Fig 1), p value <0.001 as shown in Table 1.